A commonly used asthma treatment appears to reduce the need for hospitalizations as well as recovery time for COVID-19 patients if given within seven days of symptoms appearing, researchers at the University of Oxford said on Tuesday.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
The findings were made following a mid-stage study of the steroid budesonide, sold as Pulmicort by AstraZeneca Plc and also used for treating smoker’s lung.
Researchers from Tel Aviv’s Ichilov Medical Center developed a coronavirus therapy that was found to cure COVID-19 in 3-5 days in most volunteers who received the drug.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
EXO-CD24 is a medication delivered directly to the lungs, where it’ll help prevent the immune system dealing with COVID-19 from overreacting and causing complications.
The drug is administered once a day for five minutes via inhalation. In Phase 1 trials, 29 out of 30 people suffering from moderate to severe COVID-19 recovered within 3-5 days, and all of them survived.
Most people who have Covid-19 develop a decent immune response.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
“But this guy’s response is 100 to 1,000-fold that,” Turville said.
“His response is that good. To put it in context, we are eight or nine months out since he was infected. And he still ranks in the top 1% of responders, so what that means is if we could ever bottle a vaccine that could mimic his response, you’d want to do it. I would say that we’re going to see him responding just as well probably a year out, and maybe after about two years we might start to see some response decay.”
People may soon be offered a "spit in a pot" coronavirus test, after promising trial results.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
The LampORE test checks for the virus in saliva samples, and work carried out with the help of more than 1,000 NHS volunteers shows it is good at finding cases, even if someone has no symptoms.
Researchers think a promising coronavirus treatment is 30 times more potent than remdesivir and can work against the highly infectious new mutations.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
Cancer drug plitidepsin can speed up the recovery of patients and, a study said a few months ago.
A UCSF-led team has two studies out, indicating that the drug is more efficient than remdesivir and can kill the UK mutation.
Plitidepsin doesn’t target the virus directly, but rather a human protein that the virus needs to replicate.
About one in 10 people across the UK tested positive for Covid-19 antibodies in December, roughly double the October figure, data has shown.This is just in the people who were tested.
Estimates from the Office for National Statistics suggest between 8% of people in Northern Ireland and 12% of people in England showed signs of past Covid infection.
Moderna Inc said on Tuesday it had received a report from California’s health department that several people at a center in San Diego were treated for possible allergic reactions to its COVID-19 vaccine from a particular batch.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
The company’s comments come after California’s top epidemiologist on Sunday issued a statement recommending providers pause vaccination from lot no. 41L20A due to possible allergic reactions that are under investigation.
Behavioural psychologist says many people mistakenly think they are safe as soon as they receive jabI'm pretty sure that most people on Diaspora* aren't stupid, and won't just get their vaccination and go out and party. But I'm posting this in case you know some people who are likely to do just that.
Some of the people infected with the novel coronavirus who survive COVID-19 will then experience persistent symptoms for weeks or even months after the illness, in what’s known as “Long COVID.”#science #medicine #health #Covid-19 #CoronaVirus #pandemic
Doctors are still trying to understand the lingering symptoms, with the Westchester Medical Center in New York running a treatment and study program for long haulers.
Now, a new report explains another strange coronavirus symptom that can appear with Long COVID: Some people have experienced skin peeling off their hands and a strange purple discoloration in their fingers.
Cellular (T-cell) immunity against the virus that causes Covid-19 is likely to be present within most adults six months after primary infection, with levels considerably higher in patients with symptoms, a study suggests.#science #medicine #health #Covid-19 #CoronaVirus #pandemic
The data offers another piece of the puzzle that could be key to understanding whether previous Sars-CoV-2 infections – the virus behind Covid-19 – can prevent reinfection, and if so, for how long.
The 3000+ mile border US/#Canada It's stark. MORE https://t.co/GB87cNcSXD" / Twitterhttps://twitter.com/Laurie_Garrett/status/1321627987847139329
Researchers tested a cancer drug called plitidepsin as a coronavirus therapy and discovered it can block the virus’s ability to replicate.https://bgr.com/2020/10/25/coronavirus-treatment-plitidepsin-cancer-drug-spain-trial/
The use of plitidepsin reduced viral loads after just seven days and improved blood test markers for inflammation.
Nearly 40% of a limited group of patients who received various doses of plitidepsin were discharged after just eight days in the hospital.
To efficiently infect human cells, SARS-CoV-2, the virus that causes COVID-19, is able to use a receptor called Neuropilin-1, which is very abundant in many human tissues including the respiratory tract, blood vessels and neurons. The breakthrough discovery was made by a German-Finnish team of researchers led by neuroscientists Mika Simons, Technical University of Munich, Germany and virologist Giuseppe Balistreri, Faculty of Biological and Environmental Sciences, University of Helsinki, Finland.#science #medicine #health #Covid-19 #CoronaVirus #pandemic